London: Researchers have discovered a gene that plays a central role in black skin cancer, also known as melanoma.
Suppressing this gene in mice inhibits the development of melanoma and its proliferation – a discovery that could pave the way for new forms of therapy.
Melanoma is particularly aggressive and becoming increasingly common in Switzerland, and despite intensive research there is still no treatment.
Until recently, it was assumed that a tumour was composed of many equivalent cells that all multiply malignantly and can thus contribute towards tumour growth.
According to a more recent hypothesis, however, a tumour might also consist of malignant cancer stem cells and other less aggressive tumour cells.
Normally, stem cells are responsible for the formation of organs. Cancer stem cells can divide in a very similar way and develop into other tumour cells to form the tumour.
Efficient tumour therapy thus primarily needs to fight cancer stem cells. Consequently, a team of stem-cell researchers from the University of Zurich headed by Professor Sommer decided to find out whether mechanisms that are important for normal stem cells also play a role in cancer stem cells.
Melanoma cells are rogue skin-pigment cells formed by so-called neural crest stem cells during embryonic development. Professor Sommer’s group teamed up with dermatologists and pathologists to investigate whether cells with characteristics of these specific stem cells are present in human tumour tissue.
“This was indeed the case, as we were able to prove based on numerous biopsies performed on melanoma patients,” Sommer said.
In particular, one gene that effectively controls the stem-cell program was highly active in all the tumour tissue studied.
This gene, which is known as “Sox10”, is essential for cell division and the survival of stem cells.
The next step for the Zurich researchers was to test how Sox10 works in human melanoma cells.
They determined that the gene also controls a stem-cell program in cancer cells and is necessary for cell division.
In order to corroborate these findings in a living organism, the researchers ultimately used a mouse which carried similar genetic mutations to those found in human melanoma and thus developed black skin cancer spontaneously.
Astonishingly, the suppression of Sox10 in this animal model completely inhibited the formation and spread of cancer.
“Our research demonstrates that a tumour could probably be treated by attacking its stem cells,” Sommer added.
The study has been published in Nature Cell Biology.
ANI
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookies Setting
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device and the processing of information obtained via those cookies (including about your preferences, device and online activity) by us and our commercial partners to enhance site navigation, personalise ads, analyze site usage, and assist in our marketing efforts. More information can be found in our Cookies and Privacy Policy. You can amend your cookie settings to reject non-essential cookies by clicking Cookie Settings below.
Manage Consent Preferences
Strictly Necessary Cookies
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work or you may not be able to login.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They are also used to limit the number of times you see an advert as well as help measure the effectiveness of an advertising campaign. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we may not know when you have visited our site, and may not be able to monitor its performance.